missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human ENPP-2/Autotaxin Antibody, R&D Systems™
Goat Polyclonal Antibody
Marca: R&D Systems AF5255-SP
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
ENPP-2/Autotaxin Polyclonal specifically detects ENPP-2/Autotaxin in Human samples. It is validated for Western Blot, Immunoprecipitation.
Especificaciones
| ENPP-2/Autotaxin | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| ATX, ATXFLJ26803, ATX-X, AUTOTAXIN, autotaxin-t, EC 3.1.4.39, ectonucleotide pyrophosphatase/phosphodiesterase 2, ectonucleotide pyrophosphatase/phosphodiesterase family member 2, E-NPP 2, ENPP2, Extracellular lysophospholipase D, Lysophosphatidic Acid, LysoPLD, NPP2, PD-IALPHA, PDNP2, PDNP2NPP2, phosphodiesterase I/nucleotide pyrophosphatase 2, plasma lysophospholipase D | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 5168 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Immunoprecipitation | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
| Q13822 | |
| ENPP2 | |
| Mouse myeloma cell line NS0-derived recombinant human ENPP-2/Autotaxin Asp49-Ile863 Accession # Q13822 | |
| 25 μg | |
| Primary | |
| Detects human ENPP-2 in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant human (rh) ENPP-5 and rhENPP-7 is observed. | |
| Human | |
| IgG |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
For Research Use Only
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido